Skip to content
Catalyst

Matricaria chamomillaFinding

Matricaria chamomilla decreases Hamilton Anxiety Rating Scale (HAM-A) total score

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“QLS analysis found a significantly greater reduction over time in the mean total HAM-A score for chamomile versus placebo (60 β̂3 = −3.17, 95% CI, −6.29 to −0.45) (p=0.047).”
Quoted verbatim from A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.
This finding among the 2 findings on its endpoint

Matricaria chamomilla

Hamilton Anxiety Rating Scale (HAM-A) total score

lowers

Who
adult outpatients with mild to moderate generalized anxiety disorder (DSM-IV, baseline HAM-A >= 9)
Dose studied
220 mg capsules, 1 daily in week 1, 2 daily in week 2, titrated by HAM-A response to up to 5 daily (1100 mg/day) in weeks 5-8

Moderate evidencePMID 19593179 · 2009

02 · The study

Study
RCT
Duration
8 weeks

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7FX2GK1A9F3RDG3XQFXVAR4